Wedbush Securities Inc. lifted its holdings in abrdn Healthcare Investors (NYSE:HQH – Free Report) by 592.4% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 233,882 shares of the financial services provider’s stock after purchasing an additional 200,104 shares during the period. Wedbush Securities Inc. owned about 0.41% of abrdn Healthcare Investors worth $4,530,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in HQH. Bollard Group LLC purchased a new position in abrdn Healthcare Investors during the first quarter valued at $25,000. Geneos Wealth Management Inc. grew its holdings in abrdn Healthcare Investors by 9,232.3% during the second quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock valued at $45,000 after purchasing an additional 2,862 shares during the period. Advisory Services Network LLC purchased a new stake in abrdn Healthcare Investors in the third quarter worth about $97,000. Global Retirement Partners LLC purchased a new stake in abrdn Healthcare Investors in the fourth quarter worth about $106,000. Finally, PNC Financial Services Group Inc. bought a new position in shares of abrdn Healthcare Investors in the fourth quarter worth about $107,000. Hedge funds and other institutional investors own 32.60% of the company’s stock.
abrdn Healthcare Investors Stock Down 2.5%
HQH stock opened at $22.61 on Friday. The business’s 50-day moving average price is $22.21 and its 200-day moving average price is $20.25. abrdn Healthcare Investors has a twelve month low of $16.30 and a twelve month high of $24.85.
abrdn Healthcare Investors Dividend Announcement
About abrdn Healthcare Investors
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Featured Articles
- Five stocks we like better than abrdn Healthcare Investors
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
